Explorer

Bharat Biotech Set To Begin Phase 1 Clinical Trials For Intranasal Covid-19 Vaccine; Know All About It

Hyderabad- based pharma company Bharat Biotech will begin trials of its intranasal Covid-19 vaccine. The company has also sought approval for the emergency use of Covaxin.

New Delhi: Bharat Biotech is expected to initiate Phase-1 trials of its intranasal vaccine for Covid-19 next month. The chairman and MD Krishna Ella said on Tuesday that Bharat Biotech is likely to initiate Phase 1 trials of the intranasal vaccine. Ella said his firm is setting up two more facilities for manufacturing vaccines, including for Covaxin. According to a PTI report, he said, “I think it will enter into Phase 1 (next month) because it is going to be a single-dose vaccine.” The clinical trial process is also going to be faster," during an interactive session with Kiran Mazumdar-Shaw, Chairperson of Bengaluru-based Biocon Limited. ALSO READ| Eluru AP, Mysterious Illness: Heavy Metals Lead And Nickel Found In Blood Samples, Pesticide In Water Ella said as the upcoming vaccines for COVID-19 require two-dose intramuscular injections, a country like India needs 2.6 billion syringes and needles which may add up to pollution. He explained that keeping several issues in mind Bharat Biotech tied up with Washington University School of Medicine in St. Louis for a novel "chimp-adenovirus" (Chimpanzee adenovirus), a single-dose intranasal vaccine for Covid-19. While the Phase I trials will take place in Saint Louis University's Vaccine and Treatment Evaluation Unit, Bharat Biotech, upon obtaining the required regulatory approval, will pursue further stages of clinical trials in India and undertake large scale manufacture of the vaccine at its GMP facility located in Genome Valley, here, BB had earlier said. Bharat Biotech is also developing India's first indigenous vaccine candidate, Covaxin, with the Indian Council of Medical Research, on Monday requested for approval of its vaccine. Bharat Biotech is the third drugmaker to request government approval of its Covid vaccine. 64 ambassadors and high commissioners of various countries are visiting two key biotech companies in Hyderabad that are developing vaccines against coronavirus. They first stopped at Hyderabad-based Bharat Biotech.

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headline

I.N.D.I.A Bloc In Bihar: Here's How Congress, RJD Have Decided To Share Seats After JD-U's Exit
I.N.D.I.A Bloc In Bihar: Here's How Congress, RJD Have Decided To Share Seats After JD-U's Exit
'BJP Should Pay Rs 4,600 Crore': Congress Slams Income Tax Dept, ECI After Getting Rs 1,700-Crore Notice
'BJP Should Pay Rs 4,600 Crore': Congress Slams Income Tax Dept, ECI After Getting Rs 1,700-Crore Notice
Another Blow To Congress As I-T Dept Serves Rs 1,700-Crore Notice Ahead Of Lok Sabha Elections: Report
Another Blow To Congress As I-T Dept Serves Rs 1,700-Crore Notice Ahead Of Lok Sabha Elections
Sunita Kejriwal Launches WhatsApp Campaign To Drum Up Support For Jailed Delhi CM
Sunita Kejriwal Launches WhatsApp Campaign To Drum Up Support For Jailed Delhi CM
Advertisement
for smartphones
and tablets

Videos

ABP SHIKHAR SAMMELAN 2024: 'People Might Ask To Reveal Who Voted For Whom Soon': Rajnath On Electoral BondsABP SHIKHAR SAMMELAN 2024: POK Will Always Remain An Integral Part Of India, Says Rajnath SinghABP Shikar Sammelan 2024: Rift between Akali Dal-BJP due to farmers issues? | Rajnath SinghABP Shikhar Sammelan 2024:Rajnath Singh takes a dig at Kejriwal over his arrest in Delhi Liquor Case

Photogallery

Embed widget